BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Iroko Pharmaceuticals to Create 150 New Jobs, Space at Philadelphia Navy Yard


9/8/2011 8:18:28 AM

Iroko Pharmaceuticals .Iroko Pharmaceuticals Latest from The Business Journals Officials tally Philly Live! jobsIroko sells Canadian rights to Vancocin antibioticIroko Pharmaceuticals buys iCeutica Follow this company .will expand at the Philadelphia Navy Yard Corporate Center with a new, 56,000-square foot headquarters at the South Philadelphia site.

The expansion will allow Iroko to increase the size of its work force from about 50 people to more than 200.

Iroko, founded in 2006, first established offices in the Navy Yard in 2007.

It currently occupies about 19,000 square feet of office space there.

Liberty Property Trust .Liberty Property Trust Latest from The Business Journals Intermodal yard at Charlotte airport holds promise of delivering growthLiberty buying distribution centerEarthquake didn’t damage buildings, Phila. landlords say Follow this company .(NYSE:LRY) and Synterra Partners, both of Philadelphia, will break ground on the new four-story headquarters building, which Iroko will lease, on Wednesday.

Liberty is Investing $15.4 million in the project, which is expected to be completed during the fourth quarter of next year. It will represent the seventh commercial property Liberty has developed at the Navy Yard Corporate Center with Synterra.

Iroko is specializing in using its nanoformulation technology to create improved versions of existing nonsteroidal, anti-inflammatory drugs. Its technology allows less drug to be absorbed by the body without sacrificing efficacy.

John Vavricka, president and CEO at Iroko, said the company needs more space as it gets ready to launch its first nano-reformulated product in the United States. That product is a version of diclofenac, an existing, non-steroidal medicine used by patients with arthritis for pain relief and to reduce swelling. The company is planing to file a new drug application within the next 18 months and launch the product, if it secures Food and Drug Administration approval, in 2013.

“We’ve run out of space,” Vavricka said. “Launching a product in the United States is going to require a much large footprint.”

Osagie Imasogie, chairman of Iroko, said being at the Navy Yard Corporate Center, a Keystone Innovation Zone, will qualify the company for state and city tax credits.

“We were drawn to the Navy Yard initially because of the many advantages of being in Philadelphia and the vision of what the site could be,” said Imasogie, who is also senior managing partner of Phoenix IP Ventures, an Iroko investor. “The city is a wonderful place for the life sciences because of its highly educated work force and research infrastructure. Our management team hails from around the world, and we choose to be in Philadelphia.”




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES